
THE RETINA CARE CENTER
MEDICAL LIBRARY
Age Related Macular Degeneration (AMD)
Age related macular
degeneration (AMD) is one of the most common causes of poor vision after
age 60. Although the specific cause is unknown,
AMD seems to be part of aging. While age is the most significant risk
factor for developing AMD, heredity, blue eyes, high blood pressure,
cardiovascular disease, and smoking have also been identified as risk
factors. AMD accounts for 90 percent of new legal blindness in the US.
Nine out of 10 people who have AMD have the dry form, which results in
thinning of the macula, the area of the retina responsible for central
vision. Dry AMD takes many years to develop. Currently there is no
treatment to reverse the effects of Dry AMD. However, a recent study by
the National Institutes of Health called the Age-Related Eye Disease Study
(AREDS) showed that certain vitamins can prevent vision loss. For more
information see AREDS.
The wet form of AMD occurs much less frequently (one out of 10 people) but
is more serious. Promising AMD research is being done on many
fronts. In the meantime, high-intensity reading lamps, magnifiers and
other low-vision aids help people with AMD make the most of remaining
vision.
Back
to the top
Age Related Eye Disease Study (AREDS)
Scientists have long debated whether taking vitamin and/or
mineral supplements could help prevent, treat, or cure certain eye
conditions. Some early scientific studies seemed to show that supplements
had the potential to prevent or slow the progression of age-related
macular degeneration (AMD), although a more complete study was needed.
The Age-Related Eye Disease Study (AREDS) was a major recent study
sponsored by the National Eye Institute (NEI), one of the Federal
government’s National Institutes of Health. AREDS involved 11 major
medical centers around the country. In the study, scientist looked at the
effects of zinc and antioxidants on patients with varying stages of
age-related macular degeneration (AMD).
The results of AREDS showed a number of
important things:
-
High levels of
antioxidants and zinc can reduce the risk of vision loss from advanced
AMD by about 19% in high-risk patients (patients with intermediate AMD
or advanced AMD in one eye but not the other).
-
Supplements do not provide
significant benefit to patients with minimal AMD, nor do they improve
vision already lost to AMD.
-
While most patients in the
study experienced no serious side effects from the doses of zinc and
antioxidants used, a few taking zinc alone had urinary tract problems
that required hospitalization. Some patients taking large doses of
antioxidants experienced some yellowing of the skin. The long-term
effects of taking large doses of these supplements are still unknown.
Should I Take Nutritional Supplements?
If you
have intermediate (or advanced AMD in one eye only), talk to your
physician about taking nutritional supplements to determine if nutrients
will benefit you. The doses used in the study were:
-
Vitamin C 500 mg/day
(contraindications include kidney stones and use of coumadin)
-
Vitamin E 400 IU/day
(associated with fatigue, muscle weakness, decreased thyroid function
and risk of hemorrhagic stroke)
-
Beta-carotene 15 mg/day
(associated with yellow skin)
-
Zinc 80 mg/day, as zinc
oxide (associated with anemia, and upset stomach)
-
Copper 2 mg/day, as cupric
oxide (copper should be taken with zinc, because high dose zinc is
associated with a copper deficiency)
It is very
important to talk with your physician before taking large doses of
supplements, and to follow his dosage recommendations carefully. Some
supplements may interfere with each other or other medications. Smokers
and ex-smokers probably should not take beta-carotene, since studies have
shown a link between beta-carotene use and lung cancer among smokers.
More information on AREDS is available from the National Eye Institute of
the National Institutes of Health,
www.nei.nih.gov/amd.
Back
to the top
Branch Retinal Vein Occlusion (BRVO)
Most people
know high blood pressure and other vascular diseases pose risks to overall
health, but many may not know that high blood pressure can affect vision
by damaging veins in the eye. High blood pressure is the most common
condition associated with BRVO. About 10 to 12 percent of the people who
have BRVO also have glaucoma (high pressure in the eye).
Branch
retinal vein occlusion blocks small veins in the retina, the layer of
light-sensing cells at the back of the eye. If the blocked retinal veins
are ones that nourish the macula, the part of the retina responsible for
straight-ahead vision, some central vision is lost. During the course of
vein occlusion, sixty percent or greater will have swelling of the central
macular vision area. In about one third of people, this macular edema will
remain for over one year.
BRVO causes a painless decrease in
vision, resulting in misty or distorted vision. If the veins cover a large
area, new abnormal vessels may grow on the retinal surface, which can
bleed into the eye and cause blurred vision.
There is no cure for BRVO. Finding out
what caused the blockage is the first step in treatment. Your
ophthalmologist may recommend a period of observation, since hemorrhages
and excess fluid may subside on their own. Depending on how damaged the
veins are, laser surgery may help reduce the swelling and improve vision.
Laser surgery may also shrink the abnormal new blood vessels that are at
risk of bleeding.
If you have had a branch retinal vein
occlusion, regular visits to your ophthalmologist are essential to protect
vision.
Back
to the top
Central Retinal Vein Occlusion (CRVO)
You probably know high blood pressure
and other vascular diseases pose risks to overall health, but you may not
know that they can affect eyesight by damaging the veins in the eye.
Central retinal vein occlusion (CRVO)
blocks the main vein in the retina, the light-sensitive nerve layer at the
back of the eye. The blockage causes the walls of the vein to leak blood
and excess fluid into the retina. When this fluid collects in the
macula-the area of the retina responsible for central vision-vision
becomes blurry.
Floaters in your vision are another
symptom of CRVO. When retinal blood vessels are not working properly, the
retina grows new fragile vessels that leak blood into the vitreous, the
fluid that fills the center of the eye. Blood in the vitreous clumps and
is seen as tiny dark spots, or floaters, in the field of vision.
In severe cases of CRVO, the blocked
vein causes painful pressure in the eye. Retinal vein occlusions commonly
occur with glaucoma, diabetes, age-related vascular disease, high blood
pressure, and blood disorders.
The first step is finding what is
causing the vein blockage. There is no cure for CRVO. Your ophthalmologist
may recommend a period of observation, since hemorrhages and excess fluid
often subside on their own. Steroid injections may cause
earlier resolution of excess fluid. Laser surgery may be effective in preventing
further bleeding into the vitreous, or for treating glaucoma, but it
cannot remove hemorrhage or cure glaucoma once it is present.
Back
to the top
Central Retinal Artery Occlusion (CRAO)
You probably know high blood pressure
and other vascular diseases pose risks to your overall health, but you may
not know that they can affect your eyesight by damaging the arteries in
your eye.
CRAO usually occurs in people between the ages of 50 and 70. The most
common medical problem associated with CRAO is arteriosclerosis, hardening
of the arteries. Carotid artery disease is found in almost half of the people
with CRAO.
The most common cause of CRAO is a
thrombosis, an abnormal blood clot formation. Sometimes CRAO is caused by
an embolus, a clot that breaks off from another area of the body and is
carried to the retina by the bloodstream.
Central retinal artery occlusion (CRAO)
blocks the central artery in your retina, the light-sensitive nerve layer
at the back of the eye. The first sign of CRAO is a sudden and painless
loss of vision that leaves you barely able to count fingers or determine
light from dark.
Loss of vision can be permanent without
immediate treatment. Irreversible retinal damage occurs after 90 minutes,
but even 24 hours after symptoms begin, vision may still rarely be saved. The
goal of emergency treatment is to restore retinal blood flow. After
emergency treatment, you should have a thorough medical evaluation.
Back
to the top
Central Serous Retinopathy (CSR)
Central serous retinopathy is a small,
round, shallow swelling that develops on the retina, the light sensitive
nerve layer that lines the back of the eye. Although the swelling reduces
or distorts vision, the effects are usually temporary. Vision generally
recovers on its own within a few months.
In the initial stages of CSR, vision may
suddenly become blurred and dim. If the macula-the area of the retina
responsible for acute central vision-is not affected, there may be no
obvious symptoms.
CSR typically affects adults between the
ages of 20 to 50. People with CSR often lose their retinal swelling
without treatment, and recover their original vision within six months of
the onset of symptoms. Some people with frequent episodes may have some
permanent vision loss. Recurrences are common and can affect 20 to 50
percent of people with CSR. While the cause of CSR is unknown, it seems to
occur at times of major personal or work related stress.
As CSR usually resolves on its own, no
treatment may be necessary. Sometimes laser surgery can reduce the
swelling sooner but there is no evidence this improves the final visual
outcome. If retinal swelling persists for over three to four months or if
an examination reveals early retinal degeneration, laser surgery may be
helpful.
Back
to the top
Detached and Torn Retina (RD)
A retinal detachment is a very serious
problem that almost always causes blindness unless treated. The appearance
of flashing lights, floating objects, or a gray curtain moving across the
field of vision are all indications of a retinal detachment. If any of
these occur, see an ophthalmologist right away.
As one gets older, the vitreous, the
clear gel-like substance that fills the inside of the eye, tends to shrink
slightly and take on a more watery consistency. Sometimes as the vitreous
shrinks it exerts enough force on the retina to make it tear.
Retinal tears increase the chance of
developing a retinal detachment. Fluid vitreous, passing through the tear,
lifts the retina off the back of the eye like wallpaper peeling off a
wall. Laser surgery or cryotherapy (freezing) are often used to seal
retinal tears and prevent detachment.
If the retina is detached, it must be
reattached before sealing the retinal tear. There are three ways to repair
retinal detachments. Pneumatic retinopexy involves injecting a special gas
bubble into the eye that pushes on the retina to seal the tear. The
scleral buckle procedure requires the fluid to be drained from under the
retina before a flexible piece of silicone is sewn on the outer eye wall
to give support to the tear while it heals. Vitrectomy surgery removes the
vitreous gel from the eye, replacing it with a gas bubble, which is slowly
replaced by the body's fluids.
Back
to the top
Floaters and Flashes
Small specks or clouds moving in your
field of vision as you look at a blank wall or a clear blue sky are known
as floaters. Most people have some floaters normally but do not notice
them until they become numerous or more prominent.
In most cases, floaters are part of the
natural aging process. Floaters look like cobwebs, squiggly lines or
floating bugs, and appear to be in front of the eye, but are actually
floating inside. As we get older, the vitreous-the clear gel-like
substance that fills the inside of the eye-tends to shrink slightly and
detach from the retina, forming clumps within the eye. What you see are
the shadows these clumps cast on the retina, the light-sensitive nerve
layer lining the back of the eye.
The appearance of flashing lights comes
from the traction of the vitreous gel on the retina at the time of
vitreous separation. Flashes look like twinkles or lightning streaks. You
may have experienced the same sensation if you have ever been hit in the
eye and seen stars.
Floaters can get in the way of clear
vision, often when reading. Try looking up and then down to move the
floaters out of the way. While some floaters may remain, many of them will
fade over time.
Floaters and flashes are sometimes
associated with retinal tears. When the vitreous shrinks it can pull on
the retina and cause a tear. A torn retina is a serious problem. It can
lead to a retinal detachment and blindness. If new floaters appear
suddenly or you see sudden flashes of light, see an ophthalmologist
immediately.
Back
to the top
Fluorescein Angiography (FA)
Fluorescein angiography, a clinical test
to look at blood circulation inside the back of the eye, aids in the
diagnosis of retinal conditions associated with diabetes, age-related
macular degeneration, and other eye abnormalities. The test can also help
follow the course of a disease and monitor its treatment. It may be
repeated on multiple occasions with no harm to the eye or body.
Fluorescein, a harmless orange-red dye,
is injected into a vein in the arm. The dye travels through the body to
the blood vessels in the retina, the light-sensitive nerve layer at the
back of the eye. A special camera with a green filter flashes a blue light
into the eye and takes multiple photographs of the retina. The technique
uses regular photographic film. No X-rays are involved.
If there are abnormal blood vessels, the
dye leaks into the retina or stains the blood vessels. Damage to the
lining of the retina or atypical new blood vessels may be revealed as
well. These abnormalities are determined through a careful interpretation
of the photographs by an ophthalmologist.
The dye can discolor skin and urine
until it is removed from the body by the kidneys. There is little risk in
having fluorescein angiography, though some people may have mild allergic
reactions to the dye. Severe allergic reactions have been reported but
very rarely. Being allergic to X-ray dyes with iodine does not mean you'll
be allergic to fluorescein. Occasionally, some of the dye leaks out of the
vein at the injection site, causing a slight burning sensation that
usually goes away quickly.
Back
to the top
Lattice Degeneration
Lattice degeneration is thinning and
weakening of the retina, the light-sensitive layer of cells lining the
back of the eye, that can lead to a retinal tear.
The vitreous, a clear gel-like substance
that fills the inside of the eye, is contained in a sac loosely attached
to the retina. As one ages, the vitreous takes on a more fluid consistency
and the sac sometimes separates from the retina. In lattice degeneration,
there are places where the sac is strongly attached to the retina and
pulls on it. This pulling weakens the retina and creates lattice lesions
that look like white crisscrossing lines on the retina.
If part of the vitreous sac becomes
detached from the retina, the friction and pulling where it is still
attached can create a tear in the retina. Lattice degeneration can
sometimes cause retinal detachments when holes or tears in the lattice
formation permit vitreous fluid to get under the retina.
Fortunately, most people with lattice
degeneration do not develop a retinal detachment. Preventive treatment of
lattice degeneration has not been shown to prevent retinal detachment, but
lattice degeneration should be monitored. If you have a history of lattice
degeneration, you should be aware of the symptoms of retinal tears and
detachment.
Back
to the top
Macular Edema
Macular edema is swelling of the macula,
the small area of the retina responsible for central vision. The edema is
caused by fluid leaking from retinal blood vessels. Central vision, used
for reading and other close detail work, is affected.
Because the macula is surrounded by many
tiny blood vessels, anything affecting them, such as a medical condition
affecting blood vessels elsewhere in the body or an abnormal condition
originating in the eye, can cause macular edema.
Retinal blood vessel obstruction, eye
inflammation, and age-related macular degeneration have all been
associated with macular edema. The macula may also be affected by
swelling following cataract extraction, though typically this resolves
itself naturally.
Treatment seeks to remedy the underlying
cause of the edema. Eyedrops, injections of cortisone around the eye or
laser surgery can be used to treat macular edema. Recovery depends on
the severity of the condition causing the edema.
Back
to the top
Macular Hole
The macula is the part of the retina
responsible for acute central vision, the vision one uses for reading,
watching television, and recognizing faces. A macular hole is a small
round opening in the macula. The hole causes a blind spot or blurred area
directly in the center of your vision.
Most macular holes occur in the elderly.
When the vitreous (the gel-like substance inside the eye) ages and
shrinks, it can pull on the thin tissue of the macula, causing a tear that
can eventually form a small hole. Sometimes injury or long-term swelling
can cause a macular hole. No specific medical problem is known to cause
macular holes.
Vitrectomy
surgery, the only treatment for a macular hole, removes the vitreous gel
and scar tissue pulling on the macula and keeping the hole open. The eye
is then filled with a special air bubble to push against the macula and
close the hole. The air bubble will gradually dissolve, but the patient
must maintain a face down position for one to two weeks to keep the gas
bubble in contact with the macula. Success of the surgery often depends on
how well the position is maintained.
With
treatment, most macular holes shrink and some of the lost central vision
slowly returns. The amount of visual improvement typically depends on the
length of time the hole was present. Some people with normal vision in
the other eye may not want surgery, since vitrectomy surgery cannot
completely restore vision.
Back
to the top
Macular Pucker
The retina
is a thin layer of nerve tissue that lines the back of the eye and
functions like the film in a camera. When light from an object passes
through to the back of the eye and falls on the retina, information is
sent to the brain and an image of the object is formed. The macula is the
most sensitive portion of the retina and is responsible for fine vision
such as reading.
A macular
pucker is caused by a transparent sheet of scar tissue that can form on
the surface of the macula. In most cases this is an aging change, but
sometimes it can result from trauma or inflammation. The scar tissue can
contract and lead to further painless distortion and blurring of central
vision. A change in eyeglasses cannot overcome this physical change.
Visual
change from a macular pucker may not be noticeable to the patient. This
is because the brain uses the best information from both eyes to produce
an image. It is only when we cover the better seeing eye that we become
aware of a difference between the eyes. Sometimes the difference may be
first detected at the eye doctor’s office when the two eyes are tested
individually.
If the
macular pucker is mild and does not significantly affect vision, the
situation can be monitored without intervention. In addition, patients
can test themselves at home with an Amsler grid. If the patient has a lot
of distortion or blurred vision, a surgical procedure called vitrectomy
can be utilized to remove the scar tissue. In most cases, the surgery is
a 60-minute outpatient procedure performed under local sedation. Healing
is gradual over the first 2-3 months. A successful procedure can limit
further worsening, and in most cases can improve central vision.
Back
to the top
Ocular Histoplasmosis Syndrome (OHS)
Ocular histoplasmosis syndrome (OHS) is
a major cause of visual impairment in the eastern and central United
States where 90 percent of adults have been exposed to histoplasma
capsulatum. This common fungus is found in molds from soil enriched
with bat, chicken or starling droppings and yeasts from animals.
Although the fungus is not found
directly in the eye, people with OHS usually test positive for previous
exposure to histoplasma capsulatum.
Histoplasmosis is usually mistaken for a
cold. The symptoms are very similar. The body's immune system normally
overcomes the infection in a few days. The only evidence of histoplasmosis
is histo spots, tiny scars on the retina. Generally histo spots do not
affect vision, but for unknown reasons, some people can have ocular
complications years or decades later.
Doctors believe that the histoplasmosis
spores travel from the lungs to the eye where they settle in the choroid,
the layer of tiny blood vessels that provides blood and nutrients to the
retina, the light-sensing layer of cells lining the back of the eye.
Ocular histoplasmosis develops when
fragile, abnormal blood vessels grow under the retina. The abnormal blood
vessels form a lesion known as choroidal neovascularization (CNV). If left
untreated, the CNV lesion can turn into scar tissue and replace the normal
retinal tissue in the macula.
The most common treatment for OHS is a
form of laser surgery called photocoagulation. The laser's small, powerful
beam of light destroys the abnormal blood vessels, as well as a small
amount of the retinal tissue. Treatment is not necessary unless the new
vessels are in the macula, the part of the retina responsible for acute
central vision.
Back
to the top
Proliferative Diabetic Retinopathy (PDR)
Proliferative
diabetic retinopathy is a complication of diabetes caused by changes in
the blood vessels of the eye. If you have diabetes, your body does not use
and store sugar properly. High blood sugar levels create changes in the
veins, arteries and capillaries that carry blood throughout the body. This
includes the tiny blood vessels in the retina, the light-sensitive nerve
layer that lines the back of the eye.
In PDR, the
retinal blood vessels are so damaged they close off. In response, the
retina grows new, fragile blood vessels. Unfortunately, these new blood
vessels are abnormal and grow on the surface of the retina, so they do not
resupply the retina with blood.
Occasionally,
these new blood vessels leak and cause a vitreous hemorrhage. Blood in the
vitreous, the clear gel-like substance that fills the inside of the eye,
blocks light rays from reaching the retina. A small amount of blood will
cause dark floaters, while a large hemorrhage might block all vision,
leaving only light and dark perception.
The new blood
vessels can also cause scar tissue to grow. The scar tissue shrinks,
wrinkling and pulling on the retina and distorting vision. If the pulling
is severe, the macula may detach from its normal position and cause vision
loss.
Laser surgery
may be used to shrink the abnormal blood vessels and reduce the risk of
bleeding. The body will usually absorb blood from a vitreous hemorrhage,
but that can take days, months or even years. If the vitreous hemorrhage
does not clear within a reasonable time, or if a retinal detachment is
detected, an operation called a vitrectomy can be performed. During a
vitrectomy, the eye surgeon removes the hemorrhage and the abnormal blood
vessels that caused the bleeding.
People with PDR sometimes have no
symptoms until it is too late to treat them. The retina may be badly
injured before there is any change in vision. There is considerable
evidence to suggest that rigorous control of blood sugar decreases the
chance of developing serious proliferative diabetic retinopathy.
Back
to the top
Retinitis Pigmentosa (RP)
Retinitis pigmentosa (RP) describes a
group of related diseases that tend to run in families and cause a slow
but progressive loss of vision. RP affects the rods and cones of the
retina, the light-sensitive nerve layer at the back of the eye, and
results in a decline in vision in both eyes. RP usually affects both eyes
equally with severity ranging from no visual problems in some families to
blindness at birth in others. RP gets its name from the fact that one of
the signs is a clumping of the retinal pigment that can be seen during
an eye exam.
The earliest symptom of retinitis
pigmentosa, usually noticed in childhood, is night blindness or difficulty
with night vision. People with normal vision adjust to the dark quickly,
but people with night blindness adjust very slowly or not at all. A loss
of side vision, or tunnel vision, is also common as RP progresses.
Unfortunately, the combination of night blindness and the loss of
peripheral vision can be severe and lead to legal blindness in many
people.
While there is a pattern of inheritance
for RP, 40% of RP patients have no known previous family history. Learning
more about RP in your family can help you and your ophthalmologist predict
how RP will affect you.
Usher's syndrome, in which a person is
both deaf and blind, can be associated with RP. The incidence of Usher's
syndrome is difficult to determine but surveys of patients suggest up to
10% of RP patients are deaf. The incidence of Usher's syndrome is three
cases per 100,000. It is the most frequent cause of combined
deaf-blindness in adults.
Considerable research is being done to
find the hereditary cause of RP. As hereditary defects are discovered it
may be possible to develop treatments to prevent progression of the
disease. While developments are on the horizon, particularly in the area
of genetic research, there is currently no cure for retinitis pigmentosa.
Nutritional supplements may have an
effect on RP. It has been reported that Vitamin A can slow the progression
of RP. Large doses of Vitamin A are harmful to the body and supplements of
Vitamin E alone may make RP worse. Vitamin E is not harmful if taken with
Vitamin A or in the presence of a normal diet. Your ophthalmologist can
advise you about the risks and benefits of Vitamin A and how much you can
safely take.
Despite visual impairment, people with
RP can maintain active and rewarding lives through the wide variety of
rehabilitative services that are available today. Until there is a cure,
periodic examinations by your ophthalmologist will keep you informed of
legitimate scientific discoveries as they develop.
Back
to the top
Retinoschisis
Retinoschisis is a genetic eye disease
that splits the retina, the light-sensitive layer of cells lining the back
of the eye. It occurs in two forms, one affecting young children, the
other older adults. Both forms usually affect both eyes, though one eye
may be worse than the other.
Because the disease is inherited on the
X chromosome, childhood retinoschisis occurs in boys more than girls. It
is usually detected because of poor vision.
If the split retina involves the
peripheral or side retina, peripheral vision is lost. One is also at risk
for a retinal detachment. But more commonly, retinoschisis affects the
macula, the area of the retina responsible for central vision. In this
location, one loses central vision.
Peripheral retinoschisis, more common in
adults, is usually caused by aging and does not affect vision, but it can
cause a retinal detachment. If detected early, a retinal detachment can be
treated with surgery or laser therapy.
Back
to the top
Toxoplasmosis
Toxoplasmosis is a common parasitic
infection. When contracted by a pregnant woman, toxoplasmosis can pose
serious risks to the unborn baby. Simple precautions can reduce the chance
of infection.
Pregnant women should avoid handling
litter boxes and eating raw meat because the parasite may originate in cat
feces or undercooked meat. If acquired during the first trimester of
pregnancy, the infection can be devastating to an infant.
Toxoplasmosis affects the retina, the
light-sensitive cells lining the back of the eye. Both eyes are usually
involved. If the infection settles in the macula, the area of the retina
responsible for central vision, good vision is lost forever.
When toxoplasmosis heals, it leaves a
scar. The infection may recur years later, sometimes near the previously
infected area. Swelling that fights the infection may cause floating spots
in one's vision, red, painful eyes, and poor vision.
Treating toxoplasmosis with oral
medications can be very effective. Pyrimethamine and sulfa drugs are the
classic antibiotics although some doctors add or substitute clindamycin.
Occasionally steroids, laser, or freezing (cryotherapy) treatments are
prescribed.
Screening tests can identify women of
childbearing age who are at risk of passing the infection to an unborn
child.
Back
to the top
Vitrectomy Surgery
Vitrectomy is a type of eye surgery used
to treat disorders of the retina (the light-sensing cells at the back of
the eye) and vitreous (the clear gel-like substance inside the eye). It
may be used to treat a severe eye injury, diabetic retinopathy, retinal
detachments, macular pucker (wrinkling of the retina) and macular holes.
During a vitrectomy operation, the
surgeon makes tiny incisions in the sclera (the white part of the eye).
Using a microscope to look inside the eye and microsurgical instruments,
the surgeon removes the vitreous and repairs the retina through the tiny
incisions. Repairs include removing scar tissue or a foreign object if
present.
During the procedure, the retina may be
treated with a laser to reduce future bleeding or to fix a tear in the
retina. An air or gas bubble that slowly disappears on its own may be
placed in the eye to help the retina remain in its proper position or a
special fluid that is later removed may be injected into the vitreous
cavity.
Recovering from vitrectomy surgery may
be uncomfortable but the procedure often improves or stabilizes vision.
Once the blood- or debris-clouded vitreous is removed and replaced with a
clear medium (often a saltwater solution), light rays can once again focus
on the retina. Vision after surgery depends on how damaged the retina was
before surgery.
Back
to the top
|